USP3 and pulmonary arterial hypertension: In summary, microRNA-146-5p can elevate the proliferation rate of HPAEC cells under hypoxia conditions by targeted modulating USP3, suggesting that microRNA-146-5p/USP3 axis may be a potential target for PAH treatment.